Dansk
Svenska
Norsk
Suomi
Deutsch
Italiano
Español
Português
Français
Nederlands
中文
Indonesia
Polski
日本語
한국어
Čeština
Ελληνικά
Türkçe
Tiếng Việt
عربي
Follow us
The latest news on the United States. Moderna has confirmed on Wednesday that its federal contract for advancing a bird flu vaccine has been terminated following a government review that cited concerns over scientific and safety benchmarks.
The mRNA-based shot was one of several candidates Moderna hoped would offset declining COVID-related revenues. While the company still sees promise in its mid-stage data and plans to pursue alternate paths, the loss of public funding could slow progress.